These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33989287)
1. A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients. Pillai SG; Siddappa CM; Ma C; Snider J; Kaushal M; Watson MA; Aft R PLoS One; 2021; 16(5):e0246139. PubMed ID: 33989287 [TBL] [Abstract][Full Text] [Related]
2. Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration. Pillai SG; Zhu P; Siddappa CM; Adams DL; Li S; Makarova OV; Amstutz P; Nunley R; Tang CM; Watson MA; Aft RL PLoS One; 2017; 12(1):e0170761. PubMed ID: 28129357 [TBL] [Abstract][Full Text] [Related]
3. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis. Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662 [TBL] [Abstract][Full Text] [Related]
4. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow. Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048 [TBL] [Abstract][Full Text] [Related]
5. NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients. Borgen E; Rypdal MC; Sosa MS; Renolen A; Schlichting E; Lønning PE; Synnestvedt M; Aguirre-Ghiso JA; Naume B Breast Cancer Res; 2018 Oct; 20(1):120. PubMed ID: 30322396 [TBL] [Abstract][Full Text] [Related]
6. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Krishnamurthy S; Bischoff F; Ann Mayer J; Wong K; Pham T; Kuerer H; Lodhi A; Bhattacharyya A; Hall C; Lucci A Cancer Med; 2013 Apr; 2(2):226-33. PubMed ID: 23634290 [TBL] [Abstract][Full Text] [Related]
7. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model. Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741 [TBL] [Abstract][Full Text] [Related]
8. Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease. Siddappa CM; Watson MA; Pillai SG; Trinkaus K; Fleming T; Aft R Breast Cancer Res Treat; 2013 Jan; 137(1):45-56. PubMed ID: 23129172 [TBL] [Abstract][Full Text] [Related]
9. Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. Daskalaki A; Agelaki S; Perraki M; Apostolaki S; Xenidis N; Stathopoulos E; Kontopodis E; Hatzidaki D; Mavroudis D; Georgoulias V Br J Cancer; 2009 Aug; 101(4):589-97. PubMed ID: 19623181 [TBL] [Abstract][Full Text] [Related]
10. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients. Volmer LL; Önder CE; Volz B; Singh AR; Brucker SY; Engler T; Hartkopf AD; Koch A Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762233 [TBL] [Abstract][Full Text] [Related]
11. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer. Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up. Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892 [TBL] [Abstract][Full Text] [Related]
13. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients. Schindlbeck C; Andergassen U; Hofmann S; Jückstock J; Jeschke U; Sommer H; Friese K; Janni W; Rack B J Cancer Res Clin Oncol; 2013 Jun; 139(6):1055-62. PubMed ID: 23525580 [TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291 [TBL] [Abstract][Full Text] [Related]
15. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913 [TBL] [Abstract][Full Text] [Related]
16. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Riethdorf S; Pantel K Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients. Hartkopf AD; Wallwiener M; Hahn M; Fehm TN; Brucker SY; Taran FA Cancer Res Treat; 2016 Jan; 48(1):115-24. PubMed ID: 25687853 [TBL] [Abstract][Full Text] [Related]
18. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Demeulemeester J; Kumar P; Møller EK; Nord S; Wedge DC; Peterson A; Mathiesen RR; Fjelldal R; Zamani Esteki M; Theunis K; Fernandez Gallardo E; Grundstad AJ; Borgen E; Baumbusch LO; Børresen-Dale AL; White KP; Kristensen VN; Van Loo P; Voet T; Naume B Genome Biol; 2016 Dec; 17(1):250. PubMed ID: 27931250 [TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse. Siddappa CM; Pillai SG; Snider J; Alldredge P; Trinkaus K; Watson MA; Aft R Breast Cancer Res Treat; 2019 Nov; 178(2):317-325. PubMed ID: 31432366 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis. Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]